PhysCade

Palo Alto, CA, United States  All United States companies → — Founded 2018
Medical Device / Hardware Specialty-Focused AI
Cardiology
Cardiology AI
Early Stage VC / Funding Raised (Grant)

Products

PhysCade System
PhysCade, Inc.
Cardiology AI
PhysCade System is an AI-driven software and hardware platform for analyzing and visualizing intra-cardiac electrophysiological data, assisting physicians in managing heart rhythm disorders and making informed clinical decisions during electrophysiology procedures.

See all 1 product →

About PhysCade

PhysCade is a healthcare AI company that specializes in developing artificial intelligence medical software designed to enhance cardiac ablation procedures and improve arrhythmia treatment workflows. Their core product, the PhysCade System, is an AI-driven software and hardware platform. It analyzes and visualizes intra-cardiac electrophysiological data collected during heart rhythm studies, providing detailed maps to identify early activation sites and other critical features in the heart during arrhythmia procedures.

This technology assists cardiologists and electrophysiologists in making more informed clinical decisions, aiming to improve the speed and clinical efficiency of complex cardiac procedures and ultimately enhance patient care for individuals with heart rhythm disorders. The PhysCade System is intended for the analysis, display, and storage of cardiac electrophysiological data and maps for physician review. It functions as an AI-enabled diagnostic tool that post-processes electrograms from compatible multi-electrode cardiac catheters during electrophysiology mapping procedures, providing outputs such as earliest activation sites, activation times, voltage, and signal quality.

Focus Areas

Cardiac electrophysiology heart rhythm disorders arrhythmia procedures AI-enabled diagnostic tools electrogram analysis medical decision support

Business Intelligence

TechnologyAI-driven software and hardware platform, advanced algorithms for EGM analysis, proprietary software on a computer workstation. Compatible with multi-electrode cardiac catheters and data acquisition systems including LabSystem Pro Acquisition (Boston Scientific), MacLab CardioLab Acquisition System (General Electric), and Ensite NavX/Precision System (Abbott).

What Physicians Need to Know

Specialization in Cardiac Electrophysiology
PhysCade specializes in cardiac electrophysiology, focusing on diagnosing and treating heart rhythm disorders (arrhythmias). They utilize advanced mapping and ablation techniques to identify and target specific areas of the heart causing abnormal rhythms. Their expertise extends to procedures like catheter ablation, including radiofrequency and cryoablation, and the implantation of pacemakers and defibrillators.
AI-Enabled Diagnostic Tools
PhysCade develops AI-enabled diagnostic tools that analyze and visualize intra-cardiac electrophysiological data. Their system post-processes electrograms collected from multi-electrode cardiac catheters during electrophysiology mapping procedures. This technology provides detailed maps identifying early activation sites, activation times, voltage, and signal quality. PhysCade's AI system can also provide real-time directional guidance during complex arrhythmia procedures like atrial fibrillation ablation, aiming to simplify and improve procedural therapy.
Electrogram Analysis
A core specialization is the advanced analysis of electrograms (EGMs). PhysCade's AI-driven platform processes millions of electrograms to identify repeating patterns and track atrial fibrillation waves, which can help predict the success of ablation procedures. This detailed analysis aids in deciphering complex arrhythmia patterns that might be hidden by the chaotic nature of conditions like atrial fibrillation. They also utilize multiscale entropy (MSE) analysis for quantitative electrogram assessment to guide catheter ablation.
Medical Decision Support
PhysCade's technology is designed to assist physicians in making more informed clinical decisions during electrophysiology procedures, ultimately improving patient care for those with heart rhythm disorders. Their AI tools provide insights that can help clinicians identify candidate ablation targets and optimize treatment strategies.
Physician Tip

PhysCade's AI-enabled system offers detailed, real-time electrogram analysis and mapping, which can significantly enhance the precision of ablation procedures and aid in identifying optimal ablation targets. The real-time directional guidance during complex arrhythmias, such as atrial fibrillation, has the potential to simplify procedures and improve efficiency, even for challenging cases. The ability to predict ablation responders based on AI-tracked AF waves can help tailor treatment strategies and manage patient expectations. Physicians should consider how PhysCade's independent, AI-driven analysis can complement existing cardiac electrophysiology lab equipment and workflows.

The PhysCade System operates independently of other medical devices in the cardiac electrophysiology lab, outside the sterile field. It is a specialized AI-driven software and hardware platform that analyzes and visualizes intra-cardiac electrophysiological data collected from compatible multi-electrode cardiac catheters. While it processes data from existing catheter systems, specific integration points with other clinical systems (e.g., EHR, other mapping systems) are not explicitly detailed in the provided information.

Products by PhysCade

1 product in the directory

PhysCade System
PhysCade, Inc.
Cardiology AI
PhysCade System is an AI-driven software and hardware platform for analyzing and visualizing intra-cardiac electrophysiological data, assisting physicians in managing heart rhythm disorders and making informed clinical decisions during electrophysiology procedures.

Videos

News, demos, and interviews about PhysCade.

Loading videos...

Videos load interactively. If none appear, search YouTube for PhysCade →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

PhysCade offers the PhysCade System, an AI-driven software and hardware platform designed to analyze and visualize intra-cardiac electrophysiological data. It helps clinicians by providing detailed maps that identify early activation sites and other features of interest in the heart during arrhythmia procedures, aiding in more informed clinical decisions and improving patient care for heart rhythm disorders.
The PhysCade System is an AI-enabled diagnostic tool that post-processes electrograms collected from compatible multi-electrode cardiac catheters during electrophysiology mapping procedures. It provides outputs such as earliest activation sites, activation times, voltage, and signal quality via proprietary software, which assists physicians in identifying ablation targets and guiding catheter movement in real-time for complex arrhythmias.
The PhysCade System complies with IEC 62304 standards and relevant FDA cybersecurity and software guidance documents, demonstrating safety and effectiveness for its intended use. It received FDA approval on June 4, 2025.
While specific pricing models are not publicly detailed, PhysCade's offerings are typically structured for institutional or professional use. Information on specific pricing plans would likely require direct inquiry. Regarding support, the company aims to provide tools that simplify procedures and enhance efficiency, implying a level of support for integration and use.
PhysCade has been noted to have equity from investors such as Lotus Capital Ventures, Red Bridge Ventures, and Zelda Ventures. Additionally, individuals associated with PhysCade have reported consulting or equity relationships with other medical and technology companies, indicating a network within the industry.
PhysCade was founded in 2018 and is headquartered in Palo Alto, CA. It is a privately held, venture capital-backed company that has raised an undisclosed amount in funding over one round, with its latest funding being a Grant (prize money) round in September 2022.

Related Companies

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

Medtronic is a global leader in healthcare technology, developing and manufacturing a vast array of medical devices and therapies. The company’s mission is to alleviate pain, restore health, and extend life for people with chronic conditions worldwide. Medtronic operates in over 150 countries, offering solutions across four main business units: Cardiovascular, Neuroscience, Medical Surgical, and […]

Philips Medical Systems Nederland B.V. is a key entity within Royal Philips, a leading global health technology company. The company focuses on improving people’s health and well-being through meaningful innovation, leveraging advanced technology and deep clinical and consumer insights to deliver integrated solutions. [6, 29] For physicians, this translates into a commitment to developing AI-enabled […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.